FINWIRES · TerminalLIVE
FINWIRES

SHA:603566

4 stories mentioning SHA:603566Updated 4d ago

Every FINWIRES story that references SHA:603566, newest first.

Asia

Pulike Biological Engineering Plans to Nix 215-Million-Yuan Project

Pulike Biological Engineering (SHA:603566) will terminate its biological products workshop renovation and expansion project, according to a weekend filing with the Shanghai bourse.The company cited slower-than-expected pet consumption market growth, declining pet medical spending, and intensified competition for the move.The project was originally budgeted at 214.8 million yuan, with 204.1 million yuan still unused.

SHA:603566
Asia

Pulike Biological Engineering Gets China Approval for Pseudorabies Jab for Pigs

Chinese agricultural authorities approved a pseudorabies live vaccine for pigs produced by Pulike Biological Engineering (SHA:603566) and subsidiary Luoyang Huizhong Biotechnology, according to a Saturday filing with the Shanghai bourse.The vaccine offers pigs immunity for six months.

SHA:603566
Asia

Pulike Biological Engineering Secures Regulator Approval for Feline Stress Relief Drug

Pulike Biological Engineering's (SHA:603566) pregabalin oral solution received a drug registration certificate from China's Ministry of Agriculture and Rural Affairs, according to a Shanghai bourse filing on Tuesday.The veterinary drug is used to relieve stress in cats during transportation, veterinary visits, and other similar situations.

SHA:603566
Asia

Pulike Biological Engineering Gets Approval for Dog Vaccine

Pulike Biological Engineering (SHA:603566) received regulatory approval for its canine distemper and parvovirus combined live vaccine.The veterinary drug was developed with subsidiaries Huizhong Biotechnology and Huizhong Animal Health, according to a Friday filing with the Shanghai bourse.Shares of the veterinary biological products manufacturer closed 2% lower Friday.

SHA:603566

Track with the FINWIRES app suite